Investment
Features
FeesSafety
Academy
More
Pluang+

National Health Investors reveals $272M in signed investment deals and $285M in potential projects.

Market News
14 Sep 2026
PRNewsWire
View Source
Bullish
National Health Investors reveals $272M in signed investment deals and $285M in potential projects.

National Health Investors, Inc. announced it has $272 million in signed Letters of Intent and $51.7 million in real estate purchase options, mainly for senior housing properties. The company plans to use proceeds from a Section 1031 exchange related to a prior portfolio sale to fund these investments, which could defer taxable gains. Additionally, it is evaluating about $285 million in further investment opportunities including sale-leasebacks and loans. These developments signal ongoing growth and strategic investment in senior housing and medical real estate sectors.

More News

Hub Group stock dips amid operating loss and leadership changes, with limited upside per analyst.

Hub Group stock dips amid operating loss and leadership changes, with limited upside per analyst.

Hub Group's stock is falling due to an expected operating loss in the first half of 2026 and mixed revenue forecasts, hitting a 52-week low. An analyst from Wells Fargo set a price target slightly below the current price, signaling limited growth pot...

Analyst Insights
Bearish
32 minutes ago
Coda Octopus beats Q3 earnings and revenue estimates with strong defense and acoustic sales.

Coda Octopus beats Q3 earnings and revenue estimates with strong defense and acoustic sales.

Coda Octopus Group reported Q3 earnings per share of $0.12 and revenue of $7.7 million, exceeding analyst expectations. The company's growth was driven by its defense engineering and acoustic businesses, which offset a decline in marine technology sa...

Company Fundamentals
Bullish
49 minutes ago
Lennar's Q3 earnings expected to drop amid housing market slowdown and Fed rate watch.

Lennar's Q3 earnings expected to drop amid housing market slowdown and Fed rate watch.

Lennar Corporation is set to report its Q3 earnings on September 16, 2026, with analysts expecting a decline in both earnings per share and revenue compared to last year. The forecasted EPS is $1.29 on revenue of about $8.32 billion, down from $2.00 ...

Company Fundamentals
Bearish
53 minutes ago
Baldwin Group to go private at $32.50/share amid downgrade and legal scrutiny

Baldwin Group to go private at $32.50/share amid downgrade and legal scrutiny

Baldwin Group is going private in a $7.7 billion all-cash deal led by Sequence Holdings and DFO Management, offering shareholders $32.50 per share, an 88% premium over the June 2026 price. The transaction will delist Baldwin from Nasdaq and is expect...

Market News
Bearish
1 hour ago
BTIG raises Cullinan Therapeutics price target to $40 after positive lung cancer trial results

BTIG raises Cullinan Therapeutics price target to $40 after positive lung cancer trial results

BTIG increased its price target for Cullinan Therapeutics to $40, reflecting a potential 93% upside from the current stock price of around $20.73. This upgrade follows successful Phase 3 trial results for zipalertinib, a treatment for non-small cell ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App